Company Overview of Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops small molecule therapeutics for the treatment of inflammatory diseases and cancer. Its products include AQX-1125, an active and selective small molecule allosteric activator of SHIP1 for the treatment of blood and immune disorders. The company was founded in 2004 and is based in Richmond, Canada.
5600 Parkwood Way
Richmond, BC V6V 2M2
Founded in 2004
Key Executives for Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Allergan Inc. (Canada)||Americas|
|GV Instruments Canada Ltd.||Americas|
|Sensium Technologies, Inc.||Americas|
Recent Private Companies Transactions
March 19, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- New York, NY | RGPPosted: Oct 21
- Parsippany, NJ | RGPPosted: Nov 27
- Parsippany, NJ | RGPPosted: Oct 21
Sponsored Financial Commentaries
To contact Aquinox Pharmaceuticals, Inc., please visit www.aqxpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.